The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNahl Group Regulatory News (NAH)

Share Price Information for Nahl Group (NAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 66.00
Bid: 65.00
Ask: 69.00
Change: 0.00 (0.00%)
Spread: 4.00 (6.154%)
Open: 66.00
High: 66.00
Low: 66.00
Prev. Close: 67.00
NAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Close Trading Update

11 Jan 2019 07:00

RNS Number : 8154M
NAHL Group PLC
11 January 2019
 

11 January 2019

 

NAHL Group PLC

("NAHL" or the "Group")

 

Pre-Close Trading Update

 

NAHL (AIM: NAH), the leading UK consumer marketing and services business focused on the UK legal services market, is today providing a trading update for the year ended 31 December 2018.

 

The Group has had a disappointing end to the year. Consequently profits and adjusted earnings per share* for Financial Year 2018 are expected to be between 5 and 10 per cent below Board expectations.

 

As previously referenced, the Personal Injury (PI) division has seen an ongoing decline in panel law firm demand as a result of the forthcoming regulatory changes. In addition, the Residential Property (RP) division continued to be impacted by the state of the housing market.

 

In the fourth quarter, heightened competitor activity in the PI division depressed enquiry volumes and increased consumer acquisition cost. Based on previous year's performance, we believed that the division's performance during December would mitigate this trend, although this proved not to be the case. This, coupled with a persistently difficult housing market, has resulted in a 2018 performance below expectations.

 

Our 2019 plans include initiatives that will address our competitive position, namely:

 

· Investment in brand recognition and further digital marketing activity in our PI division which will enhance our competitiveness although we recognise that the competitor landscape may continue to be challenging.

 

· In the RP division the new leadership team has implemented several strategic initiatives designed to return the business to growth in 2019.

 

The Group is well positioned to capitalise on the forthcoming regulatory changes and the Group's PI transformation programme is progressing well, including our ABS ventures which are trading profitably. The Group has received notification from the SRA that its ABS application for a wholly-owned law firm will be granted, which is a major step forward in NAHL's transition strategy.

 

The Group has continued to carefully manage its balance sheet and net debt at the end of 2018 was £15.5m, which was lower than expected. The Board expects to pay a final dividend for 2018 which, combined with the interim dividend, will maintain our policy of a total dividend covered twice by earnings per share.

 

From a regulatory perspective the Civil Liabilities Bill received royal assent on 20 December 2018 with implementation still planned for April 2020. No material alterations were made to the bill and the Group awaits clarification around how it will be implemented.

 

The Group's Critical Care division has continued to make good progress, trading in line with the Board's expectations.

 

NAHL will announce its Final Results for the year ended 31 December 2018 on 19 March 2019.

 

Russell Atkinson, CEO of NAHL, commented:

 

"Progress in Critical Care has been encouraging and, although market conditions have challenged our Residential Property business, we have plans in place to return to growth.

Despite a disappointing December, our Personal Injury business continues to make strong progress in its transformation agenda and our focus remains the creation of a market leading enquiry generation and volume processing business."

* Underlying earnings per share adjusts for share-based payments, amortisation of intangible assets on business combinations and exceptional items.

 

For further information please call:

 

NAHL Group plc

Russell Atkinson (CEO)

James Saralis (CFO)

 

via FTI Consulting

Tel: +44 (0) 20 3727 1000

finnCap Ltd (NOMAD & Broker)

Julian Blunt / James Thompson (Corporate Finance)

Andrew Burdis (Corporate Broking)

 

Tel: +44 (0) 20 7220 0500

FTI Consulting (Financial PR)

Alex Beagley

James Styles

Laura Saraby

 

Tel: +44 (0) 20 3727 1000

 

Notes to Editors

NAHL Group plc (AIM: NAH) is a leader in the Consumer Legal Services ("CLS") market. The Group provides services and products to individuals and businesses in the CLS market through its three divisions:

· Personal Injury provides outsourced marketing services to law firms through National Accident Helpline and claims processing services to individuals through Your Law and National Law Partners.

· Critical Care provides a range of specialist services in the catastrophic and serious injury market to both claimants and defendants through Bush and Company Rehabilitation.

· Residential Property provides marketing services to law firms and conveyancers as well as surveys to individuals through Fitzalan Partners. It also provides property searches through Searches UK.

 

More information is available at www.nahlgroupplc.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGUBUGUPBPGU
Date   Source Headline
24th Apr 20245:06 pmRNSIssue of Equity from Share Options and TVR
23rd Apr 20247:00 amRNSNotice of Results and Investor Presentation
5th Apr 20241:51 pmRNSHolding(s) in Company
5th Apr 202412:19 pmRNSResponse to speculation
8th Mar 20247:00 amRNSRenewal of Banking Facilities
24th Jan 20247:00 amRNSYear End Trading Update
30th Oct 20237:00 amRNSGrant of options under SAYE Scheme
19th Oct 20236:07 pmRNSHolding(s) in Company
26th Sep 20237:00 amRNSInterim Results
13th Sep 20237:00 amRNSNotice of Results and Investor Presentation
31st Jul 20235:00 pmRNSTotal Voting Rights
26th Jul 20237:00 amRNSHalf Year Trading Update
2nd Jun 20235:24 pmRNSDirector/PDMR Shareholding
31st May 20235:00 pmRNSTotal Voting Rights
31st May 20233:50 pmRNSIssue of Equity and Total voting rights
25th May 20231:50 pmRNSHolding(s) in Company
25th May 20231:19 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement
19th May 20233:16 pmRNSIssue of Equity from Exercise of Share Options
18th May 20237:49 amRNSHolding(s) in Company
2nd May 202312:57 pmRNSGrant of Awards under Group Share Option Plan
28th Apr 20238:28 amRNSAnnual Report & Accounts and Notice of AGM
25th Apr 20237:00 amRNSSale of Homeward Legal
24th Apr 20232:43 pmRNSHolding(s) in Company
24th Mar 20234:59 pmRNSFinal Results – replacement
22nd Mar 20237:00 amRNSFinal Results
16th Mar 20237:00 amRNSNotice of Investor Presentation
24th Jan 20237:00 amRNSYear End Trading Update and Notice of Results
5th Dec 20222:42 pmRNSHolding(s) in Company
27th Sep 20227:00 amRNSInterim Results
22nd Sep 20227:00 amRNSNotice of Results and Investor Presentation
15th Sep 20227:00 amRNSDirectorate changes
2nd Aug 20221:15 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSHalf Year Trading Update
14th Jul 20221:58 pmRNSHolding(s) in Company
7th Jul 20224:44 pmRNSHoldings in Company
15th Jun 202212:13 pmRNSResult of AGM
15th Jun 20227:00 amRNSAGM Statement
10th May 20227:00 amRNSAnnual Report & Accounts and Notice of AGM
28th Apr 20227:00 amRNSGrant of Awards under Group Share Option Plan
29th Mar 20227:00 amRNSFinal Results
15th Mar 20227:00 amRNSNotice of Investor Presentation
11th Feb 20227:00 amRNSChange of Nominated Adviser and Broker
19th Jan 20227:00 amRNSTrading Update and Revised Banking Facility
5th Jan 20225:02 pmRNSHolding(s) in Company
9th Dec 20217:00 amRNSIssue of Equity from Exercise of Share Options
14th Oct 20214:41 pmRNSSecond Price Monitoring Extn
14th Oct 20214:36 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSInterim Results
23rd Sep 20217:00 amRNSNotice of Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.